| Market Cap | ₹13,718Cr |
| ROE | 13.50% |
| P/E Ratio(TTM) | 28.61 |
| EPS(TTM) | 19.76 |
| P/B Ratio | 3.69 |
| Dividend Yield | 0.27% |
| Industry P/E | 34.85 |
| Book Value | 153.11 |
| Debt to Equity | 0.39 |
| Face Value | 1 |
| Parent Organisation | Granules India Limited |
| Managing Director | Dr. Kandiraju Rao |
| NSE Symbol | GRANULES |
| FUND NAME | AUM(%) |
|---|---|
| Tata Mid Cap Direct Plan Growth | 1.03% |
| Tata Large Cap Direct Plan Growth | 1.03% |
| Axis Value Fund Direct Growth | 0.98% |
| Edelweiss Balanced Advantage Fund Direct Growth | 0.89% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |